共 50 条
- [1] A first-in-class, first-in-human phase I trial of KPT-330 (selinexor), a selective inhibitor of unclear export (SINE) in patients (pis) with advanced solid tumorsJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Mau-Soerensen, MortenRazak, Albiruni R. A.Shields, Anthony FrankGabrall, Nashat Y.Gereeltano, John F.Shacham, SharonLassen, Ulrlk NielsRashal, TamlCooksoy, JenniferLandosman, YosofPond, GregoryOza, Amit M.Kauffman, MichaelSiu, Lillian L.Bedard, Philippe L.Mahaseth, HemchandraMlrza, Mansoor RazaMahipal, Arnit
- [2] Phase I Trial of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Advanced Acute Myelogenous Leukemia (AML)BLOOD, 2013, 122 (21)Savona, MichaelGarzon, RamiroBrown, Peter de NullyYee, KarenLancet, Jeffrey E.Gutierrez, MartinGabrail, NashatMau-Sorensen, MortenBaz, RachidByrd, John C.Kuruvilla, JohnSiegel, David S.Shacham, SharonRashal, TamiYau, Cindy Y. F.McCauley, DilaraSaint-Martin, Jean-RichardMcCartney, JohnLandesman, YosefKlebanov, BorisPond, GregOza, Amit M.Kauffman, MichaelMirza, Mansoor R.Stone, Richard M.
- [3] First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid TumorsJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4142 - +Razak, Albiruni R. AbdulMau-Soerensen, MortenGabrail, Nashat Y.Gerecitano, John F.Shields, Anthony F.Unger, Thaddeus J.Saint-Martin, Jean R.Carlson, RobertLandesman, YosefMcCauley, DilaraRashal, TamiLassen, UlrikKim, RichardStayner, Lee-AnneMirza, Mansoor R.Kauffman, MichaelShacham, SharonMahipal, Amit
- [4] A phase 1b food effect study of the first-in-class, oral, selective inhibitor of nuclear export (SINE) selinexor (KPT-330) in patients (pts) with advanced sarcomas.JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Gounder, Mrinal M.Loong, Herbert H. F.Nyquist-Schultz, KjirstenBaker, StephanieUstoyev, YelenaTanner, Lanier R.Shacham, SharonMcCauley, DilaraRashal, TamiSaint-Martin, Jean-RichardShacham, EranFriedlander, SharonTamir, SharonMarshall, TraceyLandesman, YosefKauffman, MichaelRebello, SashaMirza, Mansoor Slide RazaSchwartz, Gary K.Razak, Albiruni R. A.
- [5] Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Marks, Lianna JeanDiolaiti, DanielMundi, Prabhjot SinghGaviria, ErvinRainey, AllisonDela Cruz, FilemonCalifano, AndreaKung, Andrew
- [6] First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid TumorsONCOLOGIST, 2021, 26 (11): : 925 - +Do, Khanh T.Chow, Laura Quan ManReckamp, KarenSanborn, Rachel E.Burris, HowardRobert, FranciscoCamidge, D. RossSteuer, Conor E.Strickler, John H.Weise, AmySpecht, Jennifer M.Gutierrez, MartinHaughney, PeterHengel, ShawnaDerleth, Christina LouiseYap, Timothy A.
- [7] Preliminary Evidence Of Anti Tumor Activity Of Selinexor (KPT-330) In a Phase I Trial Of a First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Relapsed / Refractory Non Hodgkin's Lyphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)BLOOD, 2013, 122 (21)Kuruvilla, JohnGutierrez, MartinShah, Bijal D.Gabrail, Nashat Y.Brown, Peter de NullyStone, Richard M.Garzon, RamiroSavona, MichaelSiegel, David S.Baz, RachidMau-Sorensen, MortenDavids, Matthew S.Byrd, John C.Shacham, SharonRashal, TamiYau, Cindy Y. F.McCauley, DilaraSaint-Martin, Jean-RichardMcCartney, JohnLandesman, YosefKlebanov, BorisPond, GregOza, Amit M.Kauffman, MichaelMirza, Mansoor R.
- [8] A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)El-Khoueiry, Anthony B.Ning, YanYang, DongyunCole, SarahKahn, MichaelZoghbi, MarwanBerg, JenniferFujimori, MasamotoInada, TetsuhiKouji, HiroyukiLenz, Heinz-Josef
- [9] First-in-human phase I and pharmacological study of TAS-119, a selective Aurora A (AurA) kinase inhibitor, in patients (pts) with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Robbrecht, DebbieEskens, FerryCalvo, EmilianoHe, XiaominHirai, HiroshiSoni, NitalCook, NatalieDowlati, AfshinFasolo, AngelicaMoreno, VictorDe Bono, Johann S.
- [10] A phase I dose-escalation study of the oral selective inhibitor of nuclear export (SINE) KPT-330 (selinexor) in patients (pts) with relapsed/refractory acute myeloid leukemia (AML).JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)Yee, Karen W. L.Savona, MichaelSorensen, MortenBrown, PeterBlum, William G.DeAngelo, Daniel J.Gutierrez, MartinGarzon, RamiroSchuh, Andre C.Gabrail, Nashat Y.Wadleigh, MarthaLancet, Jeffrey E.Shah, Bijal D.Berdeja, Jesus G.Wagner-Johnston, Nina D.Flinn, IanRashal, TamiKauffman, MichaelShacham, SharonStone, Richard M.